| Brand Name | Rednirus Mart |
|---|---|
| Industry | Pharmaceuticals |
| Business Category | Pharmacies |
| Founded Year | 2016 |
| Franchise Started | 2019 |
| Total Franchise Outlets | 1–10 |
| Estimated Investment | INR 50,000–2,00,000 |
| Franchise Fee | INR 1,80,000 |
| Royalty Fee | Information not specified; in pharma franchises, royalties often cover brand support and ongoing guidance |
| Space Requirement | 200–400 Sq.ft |
| Expected Payback Period | 5–6 months |
Rednirus Mart operates in the pharmaceutical sector, offering PCD (Propaganda Cum Distribution) Pharma Franchise opportunities. The brand provides healthcare products, over-the-counter medicines, and wellness solutions to a B2B market. Franchise partners primarily serve pharmacies, clinics, and retail healthcare outlets. The opportunity falls under the broader category of pharmacy and pharma distribution franchises.
The core concept centers on enabling franchise partners to access Rednirus Mart’s product range and leverage its platform for local distribution. Partners focus on sales, client engagement, and territory management, while the franchisor provides products, marketing tools, and operational guidance. The model prioritizes scalable, low-investment entry into the pharmaceutical distribution sector.
Daily operations for franchise partners include:
| Pharmaceutical Formulations | Medicines for various therapeutic segments |
|---|---|
| Healthcare Products | Vitamins, supplements, and wellness aids |
| Over-the-Counter Products | Common-use medications and personal care items |
| Franchise Services | Territory management, marketing support, and client training |
Franchise partners operate as local distributors:
| Estimated Investment | INR 50,000–2,00,000 covering initial stock, franchise setup, and marketing materials |
|---|---|
| Franchise Fee | INR 1,80,000 for brand rights and onboarding support |
| Royalty Payments | Typically cover continued operational guidance and marketing assistance (amount unspecified) |
| Setup Costs | Local office or store setup, initial inventory, and promotional materials |
| Space Requirement | 200–400 Sq.ft suitable for storage, office, and client interactions |
|---|---|
| Preferred Locations | Areas with high pharmacy density or emerging healthcare markets |
| Equipment Needs | Basic storage racks, computer system for order management, and communication tools |
| Staffing Considerations | Minimal staff needed for inventory, order processing, and client support |
Revenue is generated primarily through:
Operational costs include inventory replenishment, minor staffing, and local marketing. Expected ROI occurs within 5–6 months due to low entry investment and recurring sales potential.
Rednirus Mart was established in 2016 and began franchising in 2019. The brand offers a small, scalable network of 1–10 franchise outlets and focuses on providing PCD pharma distribution across selected territories. Expansion is driven by franchise partners leveraging existing pharmaceutical networks.
Rednirus Mart offers a low-investment entry point into pharma distribution with exclusive territory rights. Its online platform simplifies ordering and marketing support, enabling franchisees to focus on client engagement and product sales.
This profile provides investors with a clear understanding of Rednirus Mart’s PCD pharma franchise, operational workflow, investment structure, and market potential.
Investment ranges from INR 50,000–2,00,000, covering inventory, franchise fee, and setup costs.
Franchisees distribute pharma products within their territory, manage client relations, and coordinate orders using the Rednirus Mart platform.
A minimum of 200–400 Sq.ft is recommended for storage and operational activities.
Payback period is typically 5–6 months, depending on client acquisition and sales volume.
Interested parties can contact Rednirus Mart to begin the onboarding process, receive training, and establish their local franchise operations.
Disclaimer: All scores, rankings, and estimates on ForeFind are independently produced editorial assessments using publicly available data and validated brand-submitted information. They are not verified facts, financial advice, or investment recommendations. Full Disclaimer.